DiaMedica Therapeutics Statistics
Total Valuation
DMAC has a market cap or net worth of $106.30 million. The enterprise value is $60.16 million.
| Market Cap | 106.30M |
| Enterprise Value | 60.16M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
DMAC has 37.96 million shares outstanding. The number of shares has increased by 43.51% in one year.
| Shares Outstanding | 37.96M |
| Shares Change (YoY) | +43.51% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 26.64% |
| Owned by Institutions (%) | 24.01% |
| Float | 23.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.29 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.14, with a Debt / Equity ratio of 0.01.
| Current Ratio | 18.14 |
| Quick Ratio | 17.93 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.20% and return on invested capital (ROIC) is -45.98%.
| Return on Equity (ROE) | -36.20% |
| Return on Assets (ROA) | -34.50% |
| Return on Capital (ROIC) | -45.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.07M |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, DMAC has paid $43,000 in taxes.
| Income Tax | 43,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.36% in the last 52 weeks. The beta is 1.73, so DMAC's price volatility has been higher than the market average.
| Beta (5Y) | 1.73 |
| 52-Week Price Change | -36.36% |
| 50-Day Moving Average | 2.78 |
| 200-Day Moving Average | 2.71 |
| Relative Strength Index (RSI) | 53.79 |
| Average Volume (20 Days) | 104,250 |
Short Selling Information
The latest short interest is 128,374, so 0.34% of the outstanding shares have been sold short.
| Short Interest | 128,374 |
| Short Previous Month | 130,935 |
| Short % of Shares Out | 0.34% |
| Short % of Float | 0.54% |
| Short Ratio (days to cover) | 6.55 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -21.49M |
| Pretax Income | -19.23M |
| Net Income | -19.27M |
| EBITDA | -19.13M |
| EBIT | -19.23M |
| Earnings Per Share (EPS) | -$0.56 |
Balance Sheet
The company has $46.52 million in cash and $380,000 in debt, giving a net cash position of $46.14 million or $1.22 per share.
| Cash & Cash Equivalents | 46.52M |
| Total Debt | 380,000 |
| Net Cash | 46.14M |
| Net Cash Per Share | $1.22 |
| Equity (Book Value) | 46.35M |
| Book Value Per Share | 1.22 |
| Working Capital | 44.87M |
Cash Flow
In the last 12 months, operating cash flow was -$20.29 million and capital expenditures -$26,000, giving a free cash flow of -$20.32 million.
| Operating Cash Flow | -20.29M |
| Capital Expenditures | -26,000 |
| Free Cash Flow | -20.32M |
| FCF Per Share | -$0.54 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DMAC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.51% |
| Shareholder Yield | -43.51% |
| Earnings Yield | -18.13% |
| FCF Yield | -19.11% |
Analyst Forecast
The average price target for DMAC is $7.00, which is 150.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 150.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 15, 2018. It was a reverse split with a ratio of 1:20.
| Last Split Date | Nov 15, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |